Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00135577
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2005-08-24
Brief Title:
Study 767905008 Extension Study Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Sponsor:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization Data
Organization:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Class:
INDUSTRY
Study ID:
ABD101684
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |